MedTrace Logo

CAB Versus Medical Therapy in Patients With AF and HF With Different EF Categories

NCT05364866 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2023-06-15

No results posted yet for this study

Summary

This study is to assess the effectiveness and safety of cryoballoon ablation comparing with medical therapy in patients with atrial fibrillation and heart failure with different ejection fraction categories.

Conditions

Interventions

DRUG

Antiarrhythmic drug Therapy

Propafenone, Sotalol and Amiodarone

DEVICE

cryoballoon ablation

Medtronic Arctic Front Advance™ Cardiac CryoAblation Catheters including 23mm and 28mm.

Sponsors & Collaborators

  • Affiliated Hospital of Nantong University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-01
Primary Completion
2023-12-31
Completion
2024-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05364866 on ClinicalTrials.gov